NCT04203758

Brief Summary

The overall aim of this study is to investigate whether a diet rich in rye fiber from wholegrain rye, compared to refined wheat, as part of a hypo-caloric diet leads to larger weight loss and lower body fat content after 12 weeks of intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
255

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 18, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

January 20, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 8, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 8, 2021

Completed
Last Updated

July 19, 2021

Status Verified

July 1, 2021

Enrollment Period

1.4 years

First QC Date

December 13, 2019

Last Update Submit

July 16, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Investigate if there is a difference in body weight at week 12

    Measured on a scale

    12 weeks

  • Investigate if there is a difference in body fat mass at week 12

    Measured by dual energy x-ray absorptiometry

    12 weeks

Secondary Outcomes (16)

  • Investigate if there are differences in subjective appetite ratings

    0 weeks, 6 weeks and 12 weeks.

  • Investigate if differences in primary endpoints (body weight) are apparent at week 6

    6 weeks

  • Investigate if differences in primary endpoints (fat mass) are apparent at week 6

    6 weeks

  • Investigate if lean body mass differs between intervention groups after 6 and 12 weeks of intervention

    6 weeks and 12 weeks

  • Investigate if abdominal fat mass differs between intervention groups after 6 and 12 weeks of intervention

    6 weeks and 12 weeks

  • +11 more secondary outcomes

Study Arms (2)

Wholegrain rye products with a high content of dietary fiber

EXPERIMENTAL

Cereal products based on wholegrain rye

Other: Cereal products based on rye

Refined wheat products with a low content of dietary fiber

ACTIVE COMPARATOR

Cereal products based on refined wheat

Other: Cereal products based on wheat

Interventions

Participants will receive a fixed amount of rye based cereals products, corresponding to approx 650 kcal/day.

Wholegrain rye products with a high content of dietary fiber

Participants will receive a fixed amount of wheat based cereals products, corresponding to approx 650 kcal/day.

Refined wheat products with a low content of dietary fiber

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women
  • Age 30-70 y
  • BMI 27-35 kg/m2
  • Hemoglobin ≥117g/l for women and for men ≥134g/l
  • Thyroid stimulating hormone (TSH) ≤4.30 mIU/L
  • Low density lipoprotein (LDL) cholesterol ≤5.30 mmol/L
  • Triglycerides ≤2.60 mmol/L
  • Signed informed consent

You may not qualify if:

  • Blood donation or participation in a clinical study with blood sampling within 30 days prior to screening visit and throughout the study
  • Unable to satisfactorily complete the 3-day weighted food record between screening visits.
  • Unable to lose ≥0.5 kg during the run-in period for men and women not having menstruation during the run-in period
  • Increased body weight, despite reported adherence to dietary intake for women with menstruation during the run-in period.
  • Using nicotine products on a daily basis (incl. chewing gum, patches, snus etc.)
  • Using e-cigarettes (regardless of nicotine content)
  • Following any weight reduction program or having followed one during the last 6 months prior to visit 1.
  • Diastolic blood pressure 105 mmHg or more at visit 1
  • Systolic blood pressure 160 mmHg or more at visit 1
  • History of stomach or gastrointestinal conditions (Inflammatory bowel disease, Crohn's disease, malabsorption, colostomy, bowel resection, gastric bypass surgery etc.)
  • More than 10 hours physical activity per week
  • History of heart failure or heart attack within 1 year prior to screening
  • Having type I diabetes
  • Receiving pharmacological treatment for type II diabetes (treatments based on life style interventions are acceptable, as long as they are compatible with the study protocol)
  • Previous gastrointestinal surgery, with the exception of minor surgeries such removal of appendix or gall bladder at least 6 months prior to screening.
  • +10 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chalmers University of Technology

Gothenburg, Sweden

Location

MeSH Terms

Conditions

ObesityOverweight

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Rikard Landberg, PhD

    Chalmers University of Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 13, 2019

First Posted

December 18, 2019

Study Start

January 20, 2020

Primary Completion

June 8, 2021

Study Completion

June 8, 2021

Last Updated

July 19, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations